Dental Floss: A novel Approach to Vaccine Delivery
Table of Contents
Researchers are exploring an unconventional method for vaccine administration: dental floss. This innovative technique targets the junctional epithelium, a crucial area of the mouth, aiming to elicit robust immune responses and offer a needle-free option for vaccination.
Targeting the junctional Epithelium for Enhanced Immunity
The study,published in Nature Biomedical engineering,highlights the potential of using dental floss to deliver vaccines directly to the junctional epithelium,a specialized tissue lining the gum pocket. This approach was initially tested with a nasal vaccine formulation, chosen for its proven efficacy in nasal delivery, to establish a benchmark for comparison.
“We chose one of the few vaccine formulations that actually works for nasal delivery because we wanted to see how junctional epithelium delivery compared to the best-case scenario for nasal delivery,” explained one of the researchers.
The research team further investigated the efficacy of this delivery method across three other major vaccine classes: proteins, inactivated viruses, and mRNA. In all instances, the junctional epithelium delivery technique successfully stimulated important antibody responses in the bloodstream and across mucosal surfaces.
An fascinating finding from the animal model was that the timing of food and water consumption immediately after “flossing” with the vaccine did not impact the immune response.
From Lab Mice to Floss Picks: Practical Request
While regular dental floss proved effective in laboratory mice, the researchers recognized its impracticality for human use. To overcome this, they transitioned to using floss picks, which consist of floss stretched between two prongs attached to a handle.
To assess the feasibility of this method in humans, researchers coated floss in floss picks with fluorescent food dye. They then recruited 27 participants, explained the concept, and asked them to attempt to deposit the dye into their epithelial junction using a floss pick.
“We found that approximately 60% of the dye was deposited in the gum pocket, which suggests that floss picks may be a practical vaccine delivery method to the epithelial junction,” stated Ingrole, a lead researcher.
The team is optimistic about these findings and is considering moving towards clinical trials. “We’re optimistic about that work and – depending on our findings – may then move toward clinical trials,” said Gill, another key researcher.
Advantages and Challenges of Floss-Based Vaccination
Beyond the enhanced mucosal antibody response, the floss-based vaccination technique offers several potential advantages. It is envisioned as an easy-to-administer method that could alleviate the common fear of needles associated with traditional vaccinations. furthermore, the researchers anticipate that this technique would be cost-comparable to existing vaccine delivery methods.
However,the approach also presents certain limitations. It would not be suitable for infants and toddlers who have not yet developed teeth. Additionally, more research is needed to understand how this method would perform in individuals with gum disease or other oral infections.
“In addition, we would need to know more about how or whether this approach would work for people who have gum disease or other oral infections,” Gill noted.The study, titled “Floss-based vaccination targets the gingival sulcus for mucosal and systemic immunization,” was supported by grants from the National Institutes of Health (NIH) and funds from the Whitacre Endowed chair in Science and Engineering at Texas Tech University. Gill, ingrole, and Shakya are listed as co-inventors on a patent related to targeting the junctional epithelium for vaccination.